HIBERCELL
HiberCell is a biotechnology company developing treatments to prevent cancer relapse and metastasis. The company was founded in 2019 and is based in New York.
HIBERCELL
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
2019-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.hibercell.com
Total Employee:
11+
Status:
Active
Contact:
212-601-2800
Email Addresses:
[email protected]
Total Funding:
158.15 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Wordpress Plugins
Similar Organizations
Abdera Therapeutics
Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Q32 Bio
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-08-16 | Genuity Science | Genuity Science acquired by HiberCell | 100 M USD |
| 2020-07-07 | Biothera | Biothera acquired by HiberCell | N/A |
Investors List
ARCH Venture Partners
ARCH Venture Partners investment in Series B - HiberCell
Huizenga Capital Management
Huizenga Capital Management investment in Series B - HiberCell
Magnetic Ventures
Magnetic Ventures investment in Series B - HiberCell
Hercules Capital
Hercules Capital investment in Debt Financing - HiberCell
Monashee Investment Management
Monashee Investment Management investment in Series B - HiberCell
Trinitas Capital
Trinitas Capital investment in Series B - HiberCell
Bristol Myers Squibb
Bristol Myers Squibb investment in Series B - HiberCell
Celgene
Celgene investment in Series A - HiberCell
ARCH Venture Partners
ARCH Venture Partners investment in Series A - HiberCell
Hillhouse Capital Group
Hillhouse Capital Group investment in Series A - HiberCell
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-30 | HiberCell Appoints Jonathan Lanfear as Chief Operating Officer |
Official Site Inspections
http://www.hibercell.com Semrush global rank: 7.28 M Semrush visits lastest month: 544
- Host name: 47.107.198.104.bc.googleusercontent.com
- IP address: 104.198.107.47
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "HiberCell"
About - HiberCell
Learn about HiberCell's story, team, and investors. Toggle navigation. About . Mission; Team; Our Science . Overview; HC-7366; HC-5404See details»
Org Chart HiberCell - The Official Board
Organizational Chart of HiberCell. HiberCell www.hibercell.com. has 86 executives and 7 subsidiaries +1 212 601 2800; Add an executive. HiberCell News . Anything missing? We …See details»
HiberCell - Crunchbase Company Profile & Funding
Additionally, HiberCell has been responsible for funding research, which suggests a solid financial position to support its scientific endeavors. Furthermore, the acquisition of DNA analysis …See details»
Our Mission - HiberCell
HiberCell was launched in 2019 with investor support from ARCH Venture Partners and other leading life science investors. With our focus on targeting stress-driven vulnerabilities, we have …See details»
HiberCell Company Profile 2024: Valuation, Funding & Investors
Abrdn, Bristol-Myers Squibb, Hercules Capital, Huizenga Capital Management, and Monashee Investment Management are 5 of 15 investors who have invested in HiberCell. Who are …See details»
HiberCell - Contacts, Employees, Board Members, Advisors & Alumni
HiberCell is a clinical-stage biotechnology company dedicated to the advancement of novel therapeutic agents targeting adaptive stress. ... Solutions. Products. Resources. Pricing. …See details»
HiberCell Company Profile - Office Locations, Competitors ... - Craft
HiberCell has 5 employees across 2 locations and $128.15 m in total funding,. See insights on HiberCell including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
HiberCell - The Org
HiberCell seeks to change that. As “the dormancy company,” they are the first company exclusively focused on therapeutically modulating the biology and mechanisms of tumor …See details»
Hibercell, Inc. Company Profile | New York, NY | Competitors ...
Find company research, competitor information, contact details & financial data for Hibercell, Inc. of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»
HiberCell - Funding, Financials, Valuation & Investors - Crunchbase
HiberCell is a clinical-stage biotechnology company dedicated to the advancement of novel therapeutic agents targeting adaptive stress. Search Crunchbase. ... How much funding has …See details»
HiberCell - LinkedIn
HiberCell is a clinical stage oncology company, dedicated to the advancement of first-in-class agents with the novel MOA of modulation of adaptive stress pathways and anti-tumor immunity.See details»
Leadership Archives - HiberCell
José Iglesias, M.D., is chief medical officer at HiberCell. He has more than 30 years of experience in oncology. Prior to working with HiberCell, José was vice president and head of translational …See details»
HiberCell - VentureRadar
HiberCell is the first company exclusively focused on tumor dormancy detection and therapeutics. The company is developing first-in-class therapeutics that target dormant disseminated tumor …See details»
HiberCell CEO and Key Executive Team | Craft.co
HiberCell's Co-Founder is Julio Aguirre-Ghiso. Other executives include Steven Gillis, Chairman, Director; Colin Goddard, Director and 1 others. See the full leadership team at Craft.See details»
HiberCell Company Overview, Contact Details & Competitors
May 19, 2021 HiberCell is a clinical stage oncology company, dedicated to the advancement of first-in-class agents with the novel MOA of modulation of adaptive stress pathways and anti …See details»
Hibercell - Overview, News & Similar companies | ZoomInfo.com
Who is Hibercell. HiberCell is a clinical-stage biotechnology company dedicated to the advancement of novel therapeutic candidates that overcome the foundational mol ecular …See details»
Contact - HiberCell
Learn more about our advances in treatment of primary tumors and metastatic cancer.See details»
HiberCell To Present New Data on Odetiglucan Plus …
Jan 18, 2005 Open-label phase 2 clinical trial is actively recruiting new patients and opening new sites Results to be presented in a poster session at SABCS 2021 on December 8, 2021 NEW …See details»
News & Publications - HiberCell
HiberCell to Present Pre-clinical Data on its Novel GCN2 Activator and PERK Inhibitor Programs at the American Association for Cancer Research (AACR) Annual Meeting 2023. Read More. …See details»